investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
+
-
Project leads
Collaborators
Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Prognosis
Fred R Hirsch
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Ming Tsao
University of Toronto
Toronto, Canada
Fred R Hirsch
University of Colorado Denver
Denver, United States
Related projects
Curtis Harris
Biomarkers in Cancer Diagnosis, Prognosis, and Therapeutic Outcome
Trachea, bronchus and lung
Pathology
Robert J Gillies
Radiomics Of Non-Small Cell Lung Cancer (NSCLC)
Trachea, bronchus and lung
Pathology
Guanghua Xiao
Integrative Analysis to Identify Therapeutic Targets for Lung Cancer
Trachea, bronchus and lung
Pathology
Alexander D Sorkin
Pathogenesis of Cancer: Role of EGF Receptor Endocytosis
Trachea, bronchus and lung
Pathology
Ernest J Feleppa
Advanced Ultrasonic Evaluation of Sentinel Lymph Nodes
Trachea, bronchus and lung
Pathology
Patricia J Hollen
A Decision Aid with HRQL Assessment to Reduce Costs in the Treatment of NSCLC
Trachea, bronchus and lung
Pathology
Andre Michael Lieber
Evaluation of Vectors Based on Group B Adenoviruses
Trachea, bronchus and lung
Pathology
Trever G Bivona
Rational Combined Inhibition of NF-kB and EGFR to Optimize Lung Cancer Treatment
Trachea, bronchus and lung
Pathology
Uwe Rix
Harnessing beneficial off-target effects of kinase inhibitors in lung cancer
Trachea, bronchus and lung
Pathology
